Test Bank For Basic & Applied Concepts of Blood Banking and
| | | | | | | | | |
Practices 5th Edition – By Paula Howard
| | | | | |
| Verified Chapter's 1 - 16 | Complete
| | | | | | |
,Table of Contents | |
Part I: Quality and Safety Issues
| | | | |
1. Quality Assurance and Regulation of the Blood Industry: Safety Issues in the Blood Bank…………
| | | | | | | | | | | | |
Foundations: Basic Sciences and Reagents
| | | | |
2. Immunology: Basic Principles and Applications in the Blood Bank …………………………………………………
| | | | | | | | |
3. Blood Banking Reagents: Overview and Applications……………………………………………………………………1
| | | | |
in Blood Banking……………………………………………………………………………………….18
| | | | Part III: Overview
| |
Groups
|
5. ABO and H Blood Group Systems and Secretor Status…………………………………………………………………
| | | | | | | | |
System……………………………………………………………………………………………………26
|
7. Other Red Cell Blood Group Systems, Human Leukocyte Antigens, and Platelet Antigens………………
| | | | | | | | | | |
Essentials of Pretransfusion Testing
| | | |
8. Antibody || | Detection || | and || | Identification……………………………………………………………………………………3
|| Testing………………………………………………………………………………………………………38
10. Blood Bank Automation for Transfusion Services……………………………………………………………………
| | | | |
Considerations in Immunohematology
| | |
11. AdverseComplicationsofTransfusions………………………………………………………………………………….46
| | |
12. Hemolytic Disease of the Fetus and Newborn…………………………………………………………………………
| | | | | |
Collecting and Testing
| | |
13. Donor Selection and Phlebotomy………………………………………………………………………………………….55
| | | |
Blood…………………………………………………………………………………………………….60
| | Part VII: Blood Comp
| | |
Transfusion Therapy
| |
15. Blood Component Preparation and Therapy…………………………………………………………………………….63
| | | |
16. Transfusion Therapy in Selected Patients……………………………………………………………………………….. 66
| | | | |
,Chapter 01: Quality Assurance and Regulation of the Blood Industry and Safety Issues in the Blood
| | | | | | | | | | | | | | |
Basic & Applied Concepts of Blood Banking and Transfusion Practices, 5th Edition
| | | | | | | | | | | |
MULTIPLE |CHOICE
1. Biosafety |levels |determine:
a. on |what |floor |certain |infectious |disease |testing |can |be |performed.
b. the |degree |of |risk |for |certain |areas |of |a |health |care |facility |to
|exposure |to | infectious |diseases.
c. the |amount |of |ventilation |required |in |a |transfusion |service.
d. how |many |biohazardous |waste |containers |a |laboratory |must |have.
ANS: | B
OSHA |defines |biosafety |levels |based |on |potential |exposure |to |infectious |material.
DIF: Level |1
2. A |laboratory |technologist |decided |she |would |like |to |bring |her |lab |coat |home |for |laundering |because
|when
it |was |returned |by |the |laboratory’s |laundry |service. | Is |this |practice |acceptable?
a. Yes, |if |she |uses |10% |bleach
b. Yes, |if |she |clears |it |with |her |supervisor
c. Yes, |as |long |as |she |removes |the |coat |and |does |not |wear |it |home
d. No, |because |the |laboratory |is |a |biosafety |level |2, |and |lab |coats |may |not
|be | removed
ANS: | D
Methods |of |transporting |the |lab |coat |and |the |risk |of |contamination |do |not |permit |health |care |worke
| for | cleaning.
DIF: Level |2
3. Personal |protective |equipment |includes:
a. safety |glasses.
b. splash |barriers.
c. masks.
d. All |of |the |above
ANS: | D
Safety |glasses, |splash |barriers, |and |masks |are |types |of |personal |protective |devices.
DIF: Level |1
4. At |what |point |in |the |employment |process |should |safety |training |take |place?
a. During |orientation |and |training
b. Following |lab |training |when |employees |are |more |familiar |with
their | responsibilities
|
c. Following |the |employees’ |first |evaluation
d. Before |independent |work |is |permitted |and |annually |thereafter
ANS: | D
The |Occupation |Safety |and |Health |Administration |requires |safety |training |before |independent |work |
| thereafter.
DIF: Level |1
, 7. Which |of |the |following |is |true |regarding |good |manufacturing |practices |(GMPs)?
a. GMPs |are |legal |requirements |established |by |the |Food |and |Drug |Administration.
b. GMPs |are |optional |guidelines |written |by |the |AABB.
c. GMPs |are |required |only |by |pharmaceutical |companies.
d. GMPs |are |part |of |the |quality |control |requirements |for |blood |products.
ANS: | A
Good |manufacturing |practices |are |requirements |established |by |the |Food |and |Drug |Administration.
DIF: Level |1
8. Which |of |the |following | is |an |example |of |an |unacceptable |record-keeping |procedure?
a. Using |dittos |in |columns |to |save |time
b. Recording |the |date |and |initials |next |to |a |correction
c. Not |deleting |the |original |entry |when |making |a |correction
d. Always |using |permanent |ink |on |all |records
ANS: | A
All |records |must |be |clearly |written. |Dittos |are |unacceptable.
DIF: Level |1
9. A |technologist |in |training | noticed |that |the |person |training |her |had |not |recorded |the |results |of |a |test
carefully | recorded |the |results |she |saw |at |a |later |time, |using |the |technologist’s |initials. |Is |this |an |ac
|
a. Yes; |all |results |must |be |recorded |regardless |of |who |did |the |test.
b. No; |she |should |have |brought |the |error |to |the |technologist’s |attention.
c. Yes; |because |she |used |the |other |technologist’s |initials.
d. Yes; |as |long |as |she |records |the |result |in |pencil.
ANS: | B
This |is |an |example |of |poor |record |keeping; |results |must |be |recorded |when |the |test |is |performed |and
|test.
DIF: Level |3
10. Unacceptable |quality |control |results |for |the |antiglobulin |test |performed |in |test |tubes |may |be |noticed
a. preventive |maintenance |has |not |been |performed |on |the |cell |washer.
b. the |technologist |performing |the |test |was |never |trained.
c. the |reagents |used |were |improperly |stored.
d. All |of |the |above
ANS: | D
Training, |equipment | maintenance, |and |reagent |quality |can |affect |quality |control.
DIF: Level |2
11. All |of |the |following |are |true |regarding |competency |testing | except:
a. it | must |be |performed |following |training.
b. it | must |be |performed |on |an |annual |basis.
c. it | is |required |only |if |the |technologist |has |no |experience.
d. retraining |is |required |if |there |is |a |failure |in |competency |testing.
ANS: | C
All |employees |must |have |competency |testing |following |training |and |annually |thereafter. |If |there |is |a
|testing, | retraining | is |required.
DIF: Level |2
| | | | | | | | | |
Practices 5th Edition – By Paula Howard
| | | | | |
| Verified Chapter's 1 - 16 | Complete
| | | | | | |
,Table of Contents | |
Part I: Quality and Safety Issues
| | | | |
1. Quality Assurance and Regulation of the Blood Industry: Safety Issues in the Blood Bank…………
| | | | | | | | | | | | |
Foundations: Basic Sciences and Reagents
| | | | |
2. Immunology: Basic Principles and Applications in the Blood Bank …………………………………………………
| | | | | | | | |
3. Blood Banking Reagents: Overview and Applications……………………………………………………………………1
| | | | |
in Blood Banking……………………………………………………………………………………….18
| | | | Part III: Overview
| |
Groups
|
5. ABO and H Blood Group Systems and Secretor Status…………………………………………………………………
| | | | | | | | |
System……………………………………………………………………………………………………26
|
7. Other Red Cell Blood Group Systems, Human Leukocyte Antigens, and Platelet Antigens………………
| | | | | | | | | | |
Essentials of Pretransfusion Testing
| | | |
8. Antibody || | Detection || | and || | Identification……………………………………………………………………………………3
|| Testing………………………………………………………………………………………………………38
10. Blood Bank Automation for Transfusion Services……………………………………………………………………
| | | | |
Considerations in Immunohematology
| | |
11. AdverseComplicationsofTransfusions………………………………………………………………………………….46
| | |
12. Hemolytic Disease of the Fetus and Newborn…………………………………………………………………………
| | | | | |
Collecting and Testing
| | |
13. Donor Selection and Phlebotomy………………………………………………………………………………………….55
| | | |
Blood…………………………………………………………………………………………………….60
| | Part VII: Blood Comp
| | |
Transfusion Therapy
| |
15. Blood Component Preparation and Therapy…………………………………………………………………………….63
| | | |
16. Transfusion Therapy in Selected Patients……………………………………………………………………………….. 66
| | | | |
,Chapter 01: Quality Assurance and Regulation of the Blood Industry and Safety Issues in the Blood
| | | | | | | | | | | | | | |
Basic & Applied Concepts of Blood Banking and Transfusion Practices, 5th Edition
| | | | | | | | | | | |
MULTIPLE |CHOICE
1. Biosafety |levels |determine:
a. on |what |floor |certain |infectious |disease |testing |can |be |performed.
b. the |degree |of |risk |for |certain |areas |of |a |health |care |facility |to
|exposure |to | infectious |diseases.
c. the |amount |of |ventilation |required |in |a |transfusion |service.
d. how |many |biohazardous |waste |containers |a |laboratory |must |have.
ANS: | B
OSHA |defines |biosafety |levels |based |on |potential |exposure |to |infectious |material.
DIF: Level |1
2. A |laboratory |technologist |decided |she |would |like |to |bring |her |lab |coat |home |for |laundering |because
|when
it |was |returned |by |the |laboratory’s |laundry |service. | Is |this |practice |acceptable?
a. Yes, |if |she |uses |10% |bleach
b. Yes, |if |she |clears |it |with |her |supervisor
c. Yes, |as |long |as |she |removes |the |coat |and |does |not |wear |it |home
d. No, |because |the |laboratory |is |a |biosafety |level |2, |and |lab |coats |may |not
|be | removed
ANS: | D
Methods |of |transporting |the |lab |coat |and |the |risk |of |contamination |do |not |permit |health |care |worke
| for | cleaning.
DIF: Level |2
3. Personal |protective |equipment |includes:
a. safety |glasses.
b. splash |barriers.
c. masks.
d. All |of |the |above
ANS: | D
Safety |glasses, |splash |barriers, |and |masks |are |types |of |personal |protective |devices.
DIF: Level |1
4. At |what |point |in |the |employment |process |should |safety |training |take |place?
a. During |orientation |and |training
b. Following |lab |training |when |employees |are |more |familiar |with
their | responsibilities
|
c. Following |the |employees’ |first |evaluation
d. Before |independent |work |is |permitted |and |annually |thereafter
ANS: | D
The |Occupation |Safety |and |Health |Administration |requires |safety |training |before |independent |work |
| thereafter.
DIF: Level |1
, 7. Which |of |the |following |is |true |regarding |good |manufacturing |practices |(GMPs)?
a. GMPs |are |legal |requirements |established |by |the |Food |and |Drug |Administration.
b. GMPs |are |optional |guidelines |written |by |the |AABB.
c. GMPs |are |required |only |by |pharmaceutical |companies.
d. GMPs |are |part |of |the |quality |control |requirements |for |blood |products.
ANS: | A
Good |manufacturing |practices |are |requirements |established |by |the |Food |and |Drug |Administration.
DIF: Level |1
8. Which |of |the |following | is |an |example |of |an |unacceptable |record-keeping |procedure?
a. Using |dittos |in |columns |to |save |time
b. Recording |the |date |and |initials |next |to |a |correction
c. Not |deleting |the |original |entry |when |making |a |correction
d. Always |using |permanent |ink |on |all |records
ANS: | A
All |records |must |be |clearly |written. |Dittos |are |unacceptable.
DIF: Level |1
9. A |technologist |in |training | noticed |that |the |person |training |her |had |not |recorded |the |results |of |a |test
carefully | recorded |the |results |she |saw |at |a |later |time, |using |the |technologist’s |initials. |Is |this |an |ac
|
a. Yes; |all |results |must |be |recorded |regardless |of |who |did |the |test.
b. No; |she |should |have |brought |the |error |to |the |technologist’s |attention.
c. Yes; |because |she |used |the |other |technologist’s |initials.
d. Yes; |as |long |as |she |records |the |result |in |pencil.
ANS: | B
This |is |an |example |of |poor |record |keeping; |results |must |be |recorded |when |the |test |is |performed |and
|test.
DIF: Level |3
10. Unacceptable |quality |control |results |for |the |antiglobulin |test |performed |in |test |tubes |may |be |noticed
a. preventive |maintenance |has |not |been |performed |on |the |cell |washer.
b. the |technologist |performing |the |test |was |never |trained.
c. the |reagents |used |were |improperly |stored.
d. All |of |the |above
ANS: | D
Training, |equipment | maintenance, |and |reagent |quality |can |affect |quality |control.
DIF: Level |2
11. All |of |the |following |are |true |regarding |competency |testing | except:
a. it | must |be |performed |following |training.
b. it | must |be |performed |on |an |annual |basis.
c. it | is |required |only |if |the |technologist |has |no |experience.
d. retraining |is |required |if |there |is |a |failure |in |competency |testing.
ANS: | C
All |employees |must |have |competency |testing |following |training |and |annually |thereafter. |If |there |is |a
|testing, | retraining | is |required.
DIF: Level |2
